Back | Next |
home / stock / veru / veru message board
Subject | By | Source | When |
---|---|---|---|
Yes, that is very suspicious. | Gman3343 | investorshub | 11/12/2022 12:32:33 AM |
Here Today, | Alleyba1 | investorshub | 11/11/2022 8:58:35 PM |
I agree with you, but I think, in | Alleyba1 | investorshub | 11/11/2022 8:55:07 PM |
Accumulate here. | klarino man | investorshub | 11/11/2022 5:16:01 PM |
Not over yet since the FDA May allow | Here Today | investorshub | 11/11/2022 4:26:22 PM |
Veru got screwed by the FDA. They didn't | Gman3343 | investorshub | 11/11/2022 2:51:02 PM |
This seems reasonable. Took a lotto premarket in | frankyahoo | investorshub | 11/11/2022 1:56:35 AM |
Oppenheimer analyst Leland Gershell maintains Veru, Inc. at | rwwest | investorshub | 11/11/2022 1:09:45 AM |
Alleyba1 In my opinion, Dr. Mario Eisenbarger, who was | Alleyba1 | investorshub | 11/10/2022 1:29:29 PM |
FDA will fuckkk every one , | Lolo12 | investorshub | 11/10/2022 1:08:47 PM |
Blood bath in here now. | Gman3343 | investorshub | 11/10/2022 12:23:54 PM |
I'm not a fan either, but I won't | Gman3343 | investorshub | 11/10/2022 2:58:50 AM |
Thank you. I will check it out. Not | frankyahoo | investorshub | 11/10/2022 2:52:31 AM |
Damn, if he only waited. I'm not selling. | Gman3343 | investorshub | 11/10/2022 2:50:07 AM |
My buddy bought $VERU puts on Monday with | frankyahoo | investorshub | 11/10/2022 2:41:18 AM |
Oh, and the FDA let's all the crap | Gman3343 | investorshub | 11/10/2022 2:32:00 AM |
My options are going to shyt. Unbelievable these | Gman3343 | investorshub | 11/10/2022 2:29:06 AM |
Karma, Steiner... KARMA!! | nonsequetor | investorshub | 11/10/2022 12:45:35 AM |
Sorry to hear you got stuck. All the | frankyahoo | investorshub | 11/09/2022 11:41:05 PM |
The FDA does not have to follow what | Alleyba1 | investorshub | 11/09/2022 11:30:37 PM |
News, Short Squeeze, Breakout and More Instantly...
MIAMI, FL, July 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced th...
MIAMI, FL, June 18, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced th...